Drug found 'remarkably' effective in common canine oral cancer
Dogs that have oral squamous cell carcinomas often need surgery that disfigures their jaws and lower their quality of ...
Raleigh TV meteorologist paused on-air work for cancer treatment. Update on when he returns
The longtime local news meteorologist has been temporarily absent from broadcasts as he manages his health, but he’ll be back ...
Medscape22d
Recurrent Squamous Cell Carcinoma In Situ of the Finger
A biopsy reveals squamous cell carcinoma (SCC) in situ. What should be the next steps in the patient's evaluation and management? After the initial consultation, the patient's biopsy specimen was ...
Combination immunotherapy before surgery may increase survival in people with head and neck cancer: Clinical trial
Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs ...
Managed Healthcare Executive13d
FDA Approves Tevimbra for Advanced Esophageal Cancer at $15,828 Per Month
Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that ...
Precision Medicine Online9h
Actinium Launches Clinical Program to Test Actimab-A With PD-1 Inhibitors in Solid Tumors
The firm will assess whether adding its CD33-targeted radiotherapy Actimab-A to PD-1 inhibitors will benefit patients more than PD-1 inhibitors alone.
Targeted Oncology4d
Kato Breaks Down FDA Approval of Tislelizumab in Esophageal Cancer
Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.